ObvioGo Now Integrated with Oracle Life Sciences Clinical One Data Collection
Collaboration adds critical decentralized trial capabilities to the Oracle Life Sciences Clinical One Data Collection solution
The integrated offering extends Oracle Health and Life Sciences Clinical R&D portfolio with ObvioGo's enterprise-grade ePRO, eConsent, and eCOA capabilities. This new direct integration enables sponsors and CROs to deploy participant-facing trial technologies configured and delivered through ObvioGo as part of a comprehensive, unified clinical trial system. By bringing these capabilities together, organizations can limit reliance on multiple third-party solutions while maintaining consistency, oversight, and scalability across global studies.
"Oracle Health and Life Sciences is focused on delivering connected, enterprise-grade solutions that help sponsors modernize clinical development," said
The integration supports efficient trial execution while maintaining data quality, operational oversight, and regulatory compliance for decentralized and hybrid study designs.
"This collaboration represents an important milestone for ObvioHealth," said
Beyond core decentralized trial functionality, deploying ObvioGo within the Oracle Health and Life Sciences Clinical One Data Collection creates a foundation for broader efficiencies across study start-up, site operations, participant engagement, and trial oversight, while maintaining consistent governance, and regulatory workflows.
"Together, ObvioHealth and Oracle Health and Life Sciences are delivering an integrated clinical trial experience that addresses the evolving needs of modern research," said
Each new Oracle Life Sciences innovation is designed to plug seamlessly into this unified data platform—leveraging Oracle Cloud Infrastructure (OCI), Oracle Life Sciences AI Application Suite, Oracle Fusion Cloud SCM, and Oracle Fusion
To learn more about how Oracle Life Sciences AI Data Platform can accelerate discovery, clinical trials, pharmacovigilance, and commercialization visit: https://www.oracle.com/life-sciences/data-intelligence/.
About ObvioHealth
ObvioHealth provides digital technology designed to support the execution of decentralized, hybrid, and traditional clinical trials across therapeutic areas. The company's ObvioGo® platform enables sponsors, CROs, and research teams to configure studies, manage trial operations, and support participant engagement within a single, unified system. By combining study design, trial oversight, and participant-facing workflows, ObvioHealth helps organizations streamline trial execution, maintain data quality, and support regulatory compliance across global research programs.
For more information, visit www.obviohealth.com.
Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company--ushering in the new era of cloud computing.
View original content to download multimedia:https://www.prnewswire.com/news-releases/obviogo-now-integrated-with-oracle-life-sciences-clinical-one-data-collection-302683125.html
SOURCE ObvioHealth
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- London Climate Action Week: New WBCSD research finds businesses say sustainability is key to competitiveness but warn of costly disorderly climate transition without stronger policy
- GSMA Launches Global Satellite Regulatory Playbook to Help Policymakers Build Future-Ready Connectivity Frameworks
- DELETED: FDA monitoring failures cited in nearly a third of pharmaceutical warning letters and rising, according to Eupry
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share